Prevention of atherosclerotic cardiovascular disease: Why are the benefits of lifestyle therapies neglected?

Dialogues in Cardiovascular Medicine

Volumn 10, Issue 2, 2005, Pages 73-86

  Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Diet; Hypertension; Lifestyle management; Metabolic syndrome; Obesity; Prevention; Risk factor; Smoking

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIS OIL; ASCORBIC ACID; BETA CAROTENE; BIOFLAVONOID; CHOLESTEROL; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; ECHINACEA EXTRACT; FISH OIL; FOLIC ACID; HYPOCHOLESTEROLEMIC AGENT; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLEIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PHYTOSTEROL; PLACEBO; PYRIDOXINE; RAPESEED OIL; SAFFLOWER OIL; SATURATED FATTY ACID; SELENIUM; TRANS FATTY ACID; UBIQUINONE; UNINDEXED DRUG;

ARTICLE; ATHEROSCLEROSIS; BEHAVIOR MODIFICATION; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CIGARETTE SMOKING; CLINICAL TRIAL; DIET THERAPY; FAT INTAKE; HEALTH BEHAVIOR; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HEALTH PROMOTION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE; MACRONUTRIENT; MEDICAL EXAMINATION; METABOLIC SYNDROME X; NONHUMAN; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVENTIVE MEDICINE; PROTEIN INTAKE; PUBLIC HEALTH SERVICE; RISK FACTOR; RISK REDUCTION; WEIGHT REDUCTION;

EID: 23844535375     PISSN: 12729949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. NCEP Expert Panel. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report. Circulation. 2002;106:314363421.
2. Grundy SM, Cleeman JI, Merz CN, et al; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
3. Keys A, Menotti A, Aravanis C, et al. The Seven Countries Study: 2,289 deaths in 15 years. Prev Med. 1984;13:141-154.
4. Gordon DJ. Cholesterol lowering reduces mortality: the statins. In: Grundy SM, ed. Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence. New York, NY: Marcel Dekker Inc; 2000:299-311.
5. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res. 1990; 31:1149-1172.
6. Mensink RP, Katan MB. Effects of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911-919.
7. Obarzanek E, Hunsberger SA, Van Horn L, et al. Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics. 1997;100:51-59.
8. Caggiula AW, Christakis G, Farrand M, et al, for the MRFIT Investigators. The Multiple Risk Intervention Trial (MRFIT). IV. Intervention on blood lipids. Prev Med. 1981; 10:443-475.
9. Zock PL, de Vries JH, Katan MB. Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Aterioscler Thromb. 1994;14:567-575.
10. Denke MA, Grundy SM. Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr. 1992;56:895-898.
11. Cater NB, Heller HJ, Denke M. Comparison of the effects of medium-chain triacylglycerols, palm oil, and high oleic acid sunflower oil on plasma triacylglycerol fatty acids and lipid and lipoprotein concentrations in humans. Am J Clin Nutr. 1997;65:41-45.
12. Bonanome A, Grundy SM. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med. 1988;318:1244-1248.
13. Mensink RP, Katan MB. Effects of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990;323:439-445.
14. Grundy SM, Barrett-Connor E, Rudel LL, Miettinen T, Spector AA. Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis. Arteriosclerosis. 1988;8:95-101.
15. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985;26:194-202.
16. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med. 1986;314:745-748.
17. Grundy SM. The optimal ratio of fat-to-carbohydrate in the diet. Annu Rev Nutr. 1999;19:325-341.
18. US Department of Health and Human Services. Food and Drug Administration. Food labeling: health claims; soy protein and coronary heart disease: proposed rule. Federal Register. 1998;63:62977-63015.
19. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R; Stresa Workshop Participants. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 2003;78:965-978.
20. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290:502-510.
21. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
22. Sacks FM, Svetkey LP, Vollmer WM, et al, for the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344:3-10.
23. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and risk of coronary disease among men. N Engl J Med. 1995;332:977-982.
24. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989;2:757-761.
25. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-785.
26. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiment of Infarct survival-4. Cardiovasc Drugs Ther. 1997:11:485-491.
27. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione Trial. Lancet. 1999;354:447-455.
28. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33.
29. Criqui MH. Alcohol and coronary heart disease: consistent relationship and public health implications. Clin Chim Acta. 1996;246:51-57.
30. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818-2825.
31. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438.
32. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
33. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. Obes Res. 1998;6(suppl 2):51S-209S.
34. US Department of Health and Human Services. Physical activity and health: a report of the Surgeon General. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1996:1-278.